Natalie J Miller

2PUBLICATIONS
11CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 19, 2025
Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials.

Peter Y Ch'en, Yuzheng Zhang, Daniel S Hippe

|Jul 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancer.

Natalie J Miller, Christina Baik, Joel W Neal

Pageof 1

Frequent Collaborators

1 joint publications

Elena Sotillo

1 joint publications

Diane Tseng

1 joint publications

Peter Y Ch'en

1 joint publications

Yuzheng Zhang